Cargando…
Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma
The aim of the present study was to investigate the expression of microRNA (miR)-338-5p in retinoblastoma(RB), thereby evaluating whether it could have potential as a biomarker to screen patients with RB from healthy controls. The results revealed that miR-338-5p was significantly upregulated in pat...
Autores principales: | Zhou, Peng, Li, Xuemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540340/ https://www.ncbi.nlm.nih.gov/pubmed/31289501 http://dx.doi.org/10.3892/ol.2019.10331 |
Ejemplares similares
-
Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2015) -
Molecular interactions of miR-338 during tumor progression and metastasis
por: Moghbeli, Meysam
Publicado: (2021) -
Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer
por: Yong, Fung Lin, et al.
Publicado: (2013) -
has_circ_0070512 promotes prostate cancer progression by regulating the miR‐338‐3p/hedgehog signaling pathway
por: Zhang, Pingxin, et al.
Publicado: (2022) -
miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5
por: Zhang, Xiaoqian, et al.
Publicado: (2017)